Alcidion Group Limited
Alcidion Group Limited
- P/E ratio
- 70.44
Your view on ALC.AX
Overview
What the company does, where it operates, and who runs it.
About Alcidion Group Limited
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Kate Quirke
- Headquarters
- 9 Yarra Street, South Yarra, VIC, AU
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Kate Quirke
- Headquarters
- 9 Yarra Street, South Yarra, VIC, AU
Alcidion Group Limited operates as a healthcare technology firm, specializing in the creation and licensing of software products across Australia, New Zealand, and the United Kingdom.
Its flagship product, Miya Precision, is a consolidated platform built on the Fast Healthcare Interoperability Resources (FHIR) standard, aimed at enabling intelligent healthcare delivery.
The company also supplies Smartpage, a mobile and web-based system designed to streamline hospital communications and task management for clinical and administrative personnel.
Additional solutions include Patientrack, a tool for real-time patient monitoring and risk screening; Silverlink, which handles patient administration; and ExtraMed, software dedicated to optimizing clinical and patient flow.
Furthermore, Alcidion provides a range of services encompassing product deployment, support and maintenance, systems integration, and data analysis. Founded in 2000 and headquartered in South Yarra, Australia, the company was formerly known as Alcidion Corporation Pty Ltd until its rebranding as Alcidion Group Limited in December 2015.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Alcidion Group Limited from FRC's valuation model, read against the market price. ALC.AX last traded at AUD 0.09, 70.4× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Alcidion Group Limited. Starting points for Alcidion Group Limited: P/E 70.4, EPS AUD 0.02, beta 1.08 — an Medical - Healthcare Information Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Alcidion Group Limited. Alcidion Group Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Alcidion Group Limited. Trailing twelve-month EPS for Alcidion Group Limited stands at AUD 0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterDec 2026 | Next quarterJun 2027 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | AUD 0.01 | AUD 0.01 | AUD 0.02 | AUD 0.03 |
| Lowest estimate | AUD 0.01 | AUD 0.01 | AUD 0.02 | AUD 0.02 |
| Highest estimate | AUD 0.01 | AUD 0.01 | AUD 0.03 | AUD 0.05 |
| Number of analysts | 1 | 1 | 3 | 3 |
| A year ago | −AUD 0.011 | −AUD 0.001 | AUD 0.021 | — |
| Growth vs a year ago | — | — | — | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterDec 2026 | Next quarterJun 2027 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | AUD 27.25M | AUD 27.30M | AUD 51.80M | AUD 55.73M |
| Lowest estimate | AUD 27.25M | AUD 27.30M | AUD 48.97M | AUD 52.23M |
| Highest estimate | AUD 27.25M | AUD 27.30M | AUD 56.69M | AUD 67.98M |
| Number of analysts | 1 | 1 | 4 | 5 |
| A year ago | AUD 17.64M | AUD 23.15M | AUD 51.64M | — |
| Growth vs a year ago | +54.5% | +17.9% | +0.3% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Alcidion Group Limited. Alcidion Group Limited has reported as a listed company since 2011. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| AYA.AXArtrya Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| BMT.AXBeamtree Holdings Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| ENL.AXEnlitic, Inc. | Healthcare | Medical - Healthcare Information Services | — | ||
| ONE.AXOneview Healthcare PLC | Healthcare | Medical - Healthcare Information Services | — | ||
| PCK.AXPainChek Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| PKY.AXPathkey.AI Ltd | Healthcare | Medical - Healthcare Information Services | — | ||
| PME.AXPro Medicus Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| RHT.AXResonance Health Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| EWLLeWellness Healthcare Corporation | Healthcare | OTC | $185,077 | ||
| FRLIFrélii, Inc. | Healthcare | OTC | $5,347 | ||
| GDRXGoodRx Holdings, Inc. | Healthcare | NASDAQ | $1.1B | ||
| HCATHealth Catalyst, Inc. | Healthcare | NASDAQ | $98.2M | ||
| HCTIHealthcare Triangle, Inc. | Healthcare | NASDAQ | $2.4M | ||
| HDVYHealth Discovery Corporation | Healthcare | OTC | $41,171 | ||
| HIQ.AXHITIQ Limited | Healthcare | ASX | — | ||
| HNGEHinge Health, Inc. | Healthcare | NYSE | $9.3B | ||
| HQYHealthEquity, Inc. | Healthcare | NASDAQ | $8.0B | ||
| HSTMHealthStream, Inc. | Healthcare | NASDAQ | $831.6M | ||
| HTFLHeartflow, Inc. Common Stock | Healthcare | NASDAQ | $4.0B | ||
| IBXGiBX Group, Inc. | Healthcare | OTC | $1,975 | ||

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Alcidion Group Limited.